Feedback / Questions
ALE.F02 - Alentis Therap
https://www.businesswire.com/news/home/20230425005701/en/Alentis-Therapeutics-Reports-Positive-Topline-Results-From-Phase-1-Multiple-ascending-Dose-Cohorts-Study
Apr 26, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next